BBP ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
ALNY	A	0.43	2.46
SRPT	C	-0.71	2.02
MIRM	B	0.59	1.98
IONS	B	1.02	1.83
TVTX	C	-1.85	1.82
UTHR	B	-1.90	1.76
AXSM	B	1.62	1.76
GILD	C	-2.65	1.73
ACAD	D	-1.58	1.73
INSM	C	-3.88	1.73
DAWN	F	0.30	1.71
TGTX	B	2.62	1.71
HRMY	B	2.97	1.69
ASND	C	-1.53	1.69
AUPH	D	0.74	1.68
AMGN	B	-0.45	1.68
HALO	B	1.38	1.66
IRWD	F	-1.77	1.65
ITCI	C	0.77	1.65
EXEL	C	-0.86	1.64
MDGL	C	0.00	1.64
BPMC	B	-1.21	1.63
LEGN	C	2.62	1.63
YMAB	D	0.09	1.63
REGN	B	-1.97	1.63
ADMA	B	-1.67	1.62
LGND	B	-2.46	1.61
KRYS	C	-0.03	1.60
ARDX	F	0.76	1.60
KNSA	C	3.52	1.58
BMRN	D	-1.51	1.58
NBIX	C	0.54	1.57
VRTX	B	-0.74	1.57
APLS	F	1.23	1.56
BIIB	C	-1.84	1.56
INCY	C	-2.30	1.56
BCRX	B	-2.14	1.56
TBPH	F	2.28	1.55
SWTX	D	0.03	1.53
RARE	F	-1.83	1.53
IOVA	F	-4.40	1.52
LXRX	F	3.75	1.52
DVAX	F	-0.54	1.51
PHAT	C	0.00	1.51
PTCT	D	2.01	1.50
AGIO	C	-0.07	1.49
SAGE	F	-1.85	1.48
FOLD	F	-0.41	1.48
GERN	C	4.56	1.45
RYTM	C	-3.61	1.44
ZLAB	F	-0.86	1.42
BGNE	F	2.81	1.40
BBIO	D	0.36	1.39
IMCR	F	3.51	1.36
NVAX	C	-3.24	1.36
CRSP	F	1.48	1.35
BNTX	F	1.40	1.34
MRNA	D	-0.96	1.33
ESPR	C	0.85	1.27
TARS	D	5.01	1.21

Represented by ETF Holdings

Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Infectious Diseases Biology Nasdaq 100 Rare Diseases S&P 500 Chemical Compounds Diabetes Medication Monoclonal Antibodies Organ Systems Pain Acid Alzheimer's Disease Cholesterol

Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic

Recent News for BioShares Biotechnology Products Fund & its Holdings

Date	Stock	Title
Jul 3	AMGN	S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3	INSM	Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week
Jul 3	SRPT	1 Soaring Growth Stock to Buy and Hold for 10 Years
Jul 3	AMGN	Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
Jul 3	INSM	Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
Jul 3	REGN	Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Jul 3	REGN	Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Jul 3	BNTX	GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Jul 3	HALO	How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin
Jul 3	MRNA	Tesla Deliveries Surprised. 3 Ways Elon Musk Can Drive the Stock Forward and a Few Other Things to Know Today.
Jul 3	REGN	Sanofi, Regeneron win EU label expansion for Dupixent in COPD
Jul 3	GILD	5 FDA decisions to watch in the third quarter
Jul 3	MRNA	Moderna’s mRNA influenza vaccine receives $176m boost
Jul 3	MRNA	Moderna Stock (NASDAQ:MRNA): Next-Gen COVID-19 Vaccine Is More Than a Rehash
Jul 3	REGN	Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
Jul 2	REGN	Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
Jul 2	INCY	S&P 500 Gains and Losses Today: Index Tops 5,500 as Powell Touts Inflation Progress
Jul 2	BIIB	Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
Jul 2	BIIB	US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments
Jul 2	IOVA	Unveiling Three US Growth Companies With High Insider Ownership

The BioShares Biotechnology Products Fund (BBP) seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index.
Exchange Traded Fund ETF Biotechnology Technology Products Biotechnology Products

ETF Components for BBP - BioShares Biotechnology Products Fund